Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Vsa polja
Naslov
Avtor
Tema
Signatura
ISBN/ISSN
Oznaka
Išči
Napredno
VEGF-A and FLT-1 tumour gene e...
Citiraj
Pošljite SMS
Pošljite email
Natisni
Izvozi zadetek
Izvozi v RefWorks
Izvozi v EndNoteWeb
Izvozi v EndNote
Permanent link
VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy
Bibliografske podrobnosti
Main Authors:
Brueckl, WM
,
Wirtz, R
,
Dimmler, A
,
Brunner, T
,
Klein, P
,
Hahn, E
,
Ficker, J
,
Wiest, G
Format:
Journal article
Izdano:
2009
Zaloga
Opis
Podobne knjige/članki
Knjižničarski pogled
Opis
Izvleček:
Podobne knjige/članki
TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
od: Papadopoulos Thomas, et al.
Izdano: (2007-08-01)
Development and Validation of a Simplified Prognostic Score in SCLC
od: Elodie Negre, MD, et al.
Izdano: (2020-03-01)
Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
od: Jin Yujuan, et al.
Izdano: (2023-05-01)
Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
od: Jiaping Liu, et al.
Izdano: (2024-06-01)
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
od: Kana Hashimoto, MD, et al.
Izdano: (2024-11-01)